Keywords: متفورمین; Sensor; Electrodeposition; Metformin; Entacapone; Silver nanoparticles;
مقالات ISI متفورمین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: متفورمین; VMH; ventromedial hypothalamic nucleus; PVN; paraventricular nucleus; DMH; dorsomedial hypothalamic nucleus; ARC; hypothalamic arcuate nucleus; LH; lateral hypothalamic area; CeA; Central amygdala; BLA; basolateral amygdala; MeA; medial amygdala; GCL; gra
Keywords: متفورمین; Wound healing; Insulin; Metformin; Sulfonylurea; Thiazolidinedione; DPP-4 inhibitor;
Keywords: متفورمین; Kidney neoplasms; Diabetes mellitus; Hydroxymethylglutaryl-CoA reductase inhibitors; Anti-inflammatory agents; Non-steroidal; Metformin; Survival;
Keywords: متفورمین; Metformin; Antitumor properties; Molecular mechanisms
Keywords: متفورمین; Breast cancer; Weight loss; Metformin; Survivorship; Trial;
Keywords: متفورمین; Diabetes mellitus; Metformin; TZDs; Incretins; DPP-4 inhibitors; SGLT2 inhibitors;
Keywords: متفورمین; Insulino resistencia; obesidad abdominal; riesgo cardiometabólico; vida sana; metformina; Insulin resistance; abdominal obesity; cardiometabolic risk; healthy lifestyle; metformin;
Keywords: متفورمین; Head and neck cancer; Diabetes mellitus; Metformin; Case-control studies
Keywords: متفورمین; Metformin; COX-2 inhibitor; Obesity; Adipose tissue inflammation; Insulin resistance; Fatty liver
Keywords: متفورمین; Diabetic nephropathy; Sitagliptin; Pioglitazone; CTGF; Metformin; Enalapril
Keywords: متفورمین; Metformin; Bovine serum albumin; Fluorescence quenching; DFT study; Docking
Keywords: متفورمین; Antioxidants; Hepatotoxicity; Inflammation; Metformin; NAFLD; Paraoxonase; SteatosisALT, Alanine aminotransferase; AMPK, Adenosine monophosphate-activated protein kinase; AST, Aspartate aminotransferase; BAT, Brown adipose tissue; CD, Chow diet; eWAT, Epi
Keywords: متفورمین; Type 2 diabetes; Metformin; Insulin; Renal insufficiency; Antidiabetic agents; Diabetic medications;
Keywords: متفورمین; Diabetes Mellitus, Type 2; Sancai powder; Metformin; Treatment outcome; Randomized controlled trial;
Keywords: متفورمین; Metformin; Proton Pump Inhibitors; Death; Hospitalization;
Keywords: متفورمین; Acute ischemic stroke; Diabetes mellitus; Stroke severity; Acute stroke outcome; Metformin;
Keywords: متفورمین; Metformin; Diabetes; Insulin; Insulin-like growth factor [IGF]; AMP-activated protein kinase [AMPK]; Mammalian target of rapamycin [mTOR]; Ovarian cancer; Endometrial cancer; Breast cancer; Chemoprevention;
Keywords: متفورمین; type 2 diabetes mellitus; prostate; bladder; kidney; metformin; testosterone
Keywords: متفورمین; intestinal absorption; intestinal epithelia; transporters; organic cation transporter; drug transport; metformin;
Keywords: متفورمین; Metformin; Sulfonylureas; Thiazolidinediones; Gliptins; GLP-1; Neuroprotection;
Keywords: متفورمین; Type 2 diabetes; Metformin; Sulfonylurea; Insulin; GLP-1 analog; DPP-4 inhibitor; SGLT-2 inhibitor;
Keywords: متفورمین; Metformin; Vitellogenin; Endocrine disruption; Juvenile; Fathead minnow;
Keywords: متفورمین; Metformin; Glucose-lowering drug; Type 2 diabetes mellitus; Polycystic ovary syndrome; Delaying onset of type 2 diabetes mellitus; Gestational diabetes;
Keywords: متفورمین; Brain; Mitochondria; Apolipoprotein E; AMPK; Metformin; Proteomics;
Keywords: متفورمین; Endothelium; Arterial stiffness; Fibrinolysis; Metformin; PCOS;
Keywords: متفورمین; Islet like cell aggregates (ICA's); Eicosapentaenoic acid (EPA); Docosahexaenoic acid (DHA); γ amino butyric acid (GABA); Metformin; Hypoxia;
Keywords: متفورمین; Exenatide; Metformin; Combination therapy; Type 2 diabetes mellitus; Gender difference;
Keywords: متفورمین; FFAs; free fatty acids; HFD; high-fat diet; HIF-1α; hypoxia inducible factor-1α; VEGF; vascular endothelial growth factor; Glut1; glucose transporter 1; DAG; diacylglycerol; PKCθ; protein kinase Cθ; PDE3B; phosphodiesterase 3B; cAMP; cyclic AMP; Metfo
Keywords: متفورمین; Metformin; Chemoprevention; Repurposing;
Keywords: متفورمین; Drug use bias; Diabetes; Treatment failure; Metformin; Sulphonylurea;
Keywords: متفورمین; Ionizing radiation; Metformin; Cytotoxicity; Genotoxicity; Human blood lymphocytes;
Keywords: متفورمین; AUC; Area under the concentration-time curve; DR; Delayed release; eGFR; Estimated glomerular filtration rate; FDA; Food and Drug Administration; GLP-1; Glucagon-like peptide 1; MALA; Metformin-associated lactic acidosis; NDA; New Drug Application; XR;
Keywords: متفورمین; GLUT; Glucose transporter; T1DM; Type-1 diabetes mellitus; T2DM; Type-2 diabetes mellitus; PKB/Akt; protein kinase B; GSK-3; glycogen synthase kinase-3; PGC-1α; peroxisome proliferator-activated receptor gamma coactivator-1α; FOXO; forkhead box O; VLDL;
Keywords: متفورمین; Aging; Resiliency; Robustness; Diet; Exercise; Caloric restriction; Rapamycin; Resveratrol; Metformin; Senolytics;
Keywords: متفورمین; early pregnancy loss; insulin resistance; metformin; polycystic ovary syndrome
Keywords: متفورمین; Metformin; Diabetes; Lactic acidosis; Adverse effect; Pharmacovigilance;
Keywords: متفورمین; acarbose; cost-minimization; metformin; type 2 diabetes;
Keywords: متفورمین; Micronuclei; Genotoxicity; Metformin; Glimepiride; Urothelial cells;
Keywords: متفورمین; Diabetes; Acidosis; Lactate; Metformin; Inpatient diabetes;
Keywords: متفورمین; Metformin (PubChem CID: 4091)Type 2 diabetes; Oxidation stress; Hs-CRP; Gender; Metformin; Statins
Keywords: متفورمین; Nursing home; diabetes; glucose-lowering; insulin; metformin;
Keywords: متفورمین; Glucose stress; Metformin; Mitochodria;
Keywords: متفورمین; Bioequivalence; generic formulations; metformin; Mexican population; pharmacokinetic
Keywords: متفورمین; Assisted reproductive technology; Metformin; Polycystic ovary syndrome; Pregnancy; Systematic review
Keywords: متفورمین; 2-DG, 2-deoxy-D-glucose; AMPK, adenosine monophosphate activated protein kinase; ATP, adenosine triphosphate; EC, esophageal cancer; ESCC, esophageal squamous cell carcinomaAMPK; Esophageal cancer; Gluconeogenesis; Metformin; Targeted therapy
Keywords: متفورمین; Oesophageal cancer; Diabetes; Metformin; Survival;
Keywords: متفورمین; Metformin; Mitochondria; Leukocyte; Endothelium; PCOS; Type 2 diabetes;
Keywords: متفورمین; Metformin; Adenosine monophosphate-activated kinase; Kidney; Fibrosis; Inflammation;
Keywords: متفورمین; CpG, cytosine–phosphate–guanine; DM, diabetes mellitus; DNA, deoxyribonucleic acid; DNMT, DNA methyltransferase; TNF-α, tumor necrosis factor-alphaProcainamide; Epigenetic mechanisms; Metformin; Diabetes mellitus